Search results
Dana Andersen Chief Technical and Manufacturing Officer Previously, he worked at Genentech for nearly 23 years, most recently as Vice President and Global Head of Technical Development Project & Portfolio Management for the Roche large and small molecule development portfolio.
View Dana Andersen’s profile on LinkedIn, a professional community of 1 billion members. Experience: Denali Therapeutics · Education: Stanford University · Location: South San Francisco · 500...
- 500+
- Denali Therapeutics
- 1.7K
- South San Francisco, California, United States
Dana Andersen joined Denali Therapeutics in 2018 as the Chief Technical and Manufacturing Officer and is responsible for overseeing the development of manufacturing processes, production, quality control & assurance and clinical supply to support the Denali portfolio.
Multiple cell culture factors can affect the glycosylation of Asn‐184 in CHO‐produced tissue‐type plasminogen activator. DC Andersen, T Bridges, M Gawlitzek, C Hoy. Biotechnology and...
Dr. Andersen joins Denali from Genentech, where he served in various roles for nearly 23 years, working most recently as Vice President and Global Head of Technical Development Project &...
Dana Andersen is Chief Technical & Manufacturing Officer at Denali Therapeutics Inc. See Dana Andersen's compensation, career history, education, & memberships.
Dana ANDERSEN, Chief Technical & Manufacturing Officer | Cited by 2,165 | of Denali Therapeutics, California | Read 19 publications | Contact Dana ANDERSEN
